OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki Health, Biotech
New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc Austin, Business, Health, Biotech, Financial
New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc Austin, Business, Health, Biotech, Financial
FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc Business, Health, Biotech, Financial
Abstract Reports Curtana's CT-179 Extends Survival as a Single Agent in a Patient-Derived Model of Diffuse Midline Glioma Austin, Biotech
Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma Business, Health, Biotech, Financial
New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) Austin, Business, Health, Biotech, Financial
Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC) Business, Health, Biotech, Financial
Preprint Reports Curtana's CT-179 Enhances Radiotherapy in an MGMT-Unmethylated Glioblastoma Model and Extends Survival as a Single Agent Austin, Biotech
Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP Business, Health, Biotech, Financial
Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP) Business, Health, Biotech, Financial
Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments Software, Biotech
Pneumonic Plague Reports From Russia Spark Surge in Demand for Respiratory Protection Austin, Health, Biotech
ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research Dallas, Health, Technology, Biotech
NOWINCLUDED's Clear the Air Brings Free Lung Health Resources & Family Giveaways to Houston Houston, Biotech
OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
Abstract Reports Curtana's CT-179 Extends Survival as a Single Agent in a Patient-Derived Model of Diffuse Midline Glioma
New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments
Pneumonic Plague Reports From Russia Spark Surge in Demand for Respiratory Protection